Back

Long-term spermidine therapy potentially protects the heart against estrogen deprivation in female rats via suppressing cardiac mitochondrial dysfunction, inflammation, oxidative stress, and apoptosis

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Diabetes and the heart (4) Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Miss Wichida KAOROP

Chiang Mai University, Chiang Mai (Thailand)

3 More presentations in this session

Presentation thumbnail
Association of dietary salt intake with diabetes mellitus in the Japanese general population
Doctor S. Nakano (Hamamatsu, JP)
Abstract Slides Video
Presentation thumbnail
Association between intensity of glycemic control with GLP-1 receptor agonists and risk of atherosclerotic cardiovascular disease: a systematic review and meta-regression
Mr D. Gomes (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Insulin pump treatment vs. multiple daily insulin injections in patients with poorly controlled type 2 diabetes mellitus: a comparison of cardiovascular effects
Doctor S. Tremamunno (Rome, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Diabetes and the heart (4)

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Spermidine attenuates left ventricular dysfunction in estrogen deprived aging rats through mitigating lipid peroxidation and mitochondrial dysfunction
thumbnail
Congress Presentation
Role of sumoylation modification of sirtuin 3 in hypertension-associated
thumbnail
Congress Presentation
NRF3-mediated mitochondrial superoxide promotes cardiomyocyte apoptosis and impairs cardiac functions by suppressing Pitx2

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources